Clinical Trial Update: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports results of a risk-adapted chemotherapy approach for younger patients with newly diagnosed standard-risk acute lymphoblas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-lymphoblastic Lymphoma
• Hypodiploid B-lymphoblastic Leukemia
• Philadelphia Chromosome-positive B-lymphoblastic Leukemia

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Lymphoblastic Leukemia, Adult B Lymphoblastic Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-06-23